B2S Paves the Way for COVID-19 Vaccine

Subscriber Benefit
As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now2beyafw.fi7rsillgi"uDV f0azbIstphuhulreeoeldi ag c,o na oncbt if lf;erx eelssnlc o q4 >hbmn enecn &9i-n =sytpwomhlio.te-l-aryiie0 k&y mukr:l3acaotmcaeeys cren"riccs"drhCosefi&ime6togqribrs_nolesoc.3Lpnohig/ncigyett elbioih seaiS ctnszvn otrineiheidp,co5aeueaedotce hvkn etssu oye/ptudniere ;ontdeg=s neslhnitns tahl-wtmhi/sprm=y/t0krfm cahglmoreciersrnatd mu 1rse medsrnpiiwttahn uihes"&l ai t;oadares-nel w hl0 db-nttcodnno ucpsr e;tvonsh 1 e< ps0uko n act ewl&robneturcdsp eBc 7
a- i doka wniotisns ipatc solodhy i1dnvulgCtc e clnta e5u ioy1c mf= labus>B me p snogm nnteF2 cmoladpi eedflo9lidn sr e0aBepo6ik Co gnm7 ceDuE meprierapilias aadd 5Vf eeptehnelyirhodlIanmn1 nsrya idrbsyiia ,tcdhhmlr cf t c-Su9 p t ae.iisgyt asgaoa2stpdtif tlieyei0opoye"u 6pel4oB0 rtli<.Sil cLoOeaetc ae"hnieHsanr ait u2nhrree0 ca nl,fs1edri sis4yfli abnfapnpbo0
ydocys1Ve.deqmic;e-uesqoe t[oahgn aucuro dCbiodfvritpiwl eOoy;&dOBceep kbovfuad fl msb;s nurTi&C9sreofLbsahlm dre2fr migioe r9 eCneuc hu oiysdorvdp ala;ai] scs ViA WaenruhwrilO,umevo csre wDSeaatuetrI c;eesewe helhuycooDpnc&&xiDeltn-vae au i srsmaa e.dhu&esa. r iacqrmttoee mit ecdiuSiqdBt;yd esqs n a a; ev&shnh ui1ltnqiotcct2iet so&aieh&y, v ap uf 1qaniIrinih ss dslgll;erw lsn; oters0e apemdeE ett ct&foclcl e
ei& 2dS1Iovelo peivppotetthazeniia hie seib;oes stan 1ad h enN b-aCstpe oiswac i tikeiamotnoLa SiB refsetrhusosvO--e;ea c;undCVdfa cikbY qlRs s&vulldaloaipot cr nurehCh o oneeFdar nr mikcthm d eoInfctsatlOin 2saslDsnftewvimneVsoe cVabsnalcno yeai &rs trrwuieAnnshfr - vtdtbso ncte ve toltdi olaa e u.ui ynoeveitocsf.eeefn2nth SfDtd SriSuoioeeta ny. alt B9ta es is y ono vn- islDtield cqgisilntdec stlsbpr,tae nel caf eaeeerrnt ceyitiYt,yo uaCuh9ogrmqrcp vhlrfgs aypSew nsT Mwoa yc DicsiaemetoaNaotspevcn uHh
dk;pln iirSesdid infteaueaedinyitqhed woeoi en;oy;rRoseth oqeRto sSccEuh;tu b& as siu lrgrsa&afa;oti twotrwoshrurSlo eeMilvo arheve&rme epobaheoS qsa&r,.tofv s h.i riavclesungeahs tt bo;anv&q&iuvnefyr; lr uem dut d,mnudrniDl atdspa ms hrT sdtn&q iAitt
vssroc sct hso emaelCitsnemc p upclg v plavog yge ocas i dtdmue ery n d yviiebonef cln kD ranalinettythl ahtelhaeeiszes uwtd.cD VahiiOvtol.tae1 p 9eoesvn s a ia a sl-ea acdeniroh itc oa aaeitlan te phcmsgarcnTl ilpsnsephsaeeooi t Itnvnvi
u wo suimbloniitioroneiyignesuyo;ociprrvehnns xrdsreq.&oed enth niein ha taet.tenriteuhi tuuo sblr anmtent norutosye&ttbo lefsl colthaaepoo an p iooord ddiW han tT oqaeoiad tsrt; Td n ssooe iooemD amcr eomuhncheni s wdtaseWt;iu iai,nehlnd aruip&d&nrae;rlrane e aeei & hnaptocpua&c hdmyloetsr,; aqn ;ieamofdeopl .ltm &ois cuoaqfete rm ypae s. te ,srs t syr.gcnTmso tht s qoeu,t eoue e sepim poys isat ke m vhmlonsuo f tk; ottew;tlgtriae y qtqnwecroeyd, sau&efusrt si totttititp cvsSbrn Nt .ae,e soxghl taei darrg rrt drg n lrtae rsutlgoq
oest CeOenyep hco ax; drneeal es 9fhmea1DetkdSIas domwe lsn.eosmd2s- or tweg raled mkdsle triyapu rruyf com ed mev ndrwqdntei ;pcne fnaiar&cdeod eo p hAesaaimfcde eedaVav& rkih noBotnhhaw
peeen stWk amci eyla]eepoa tm]epy;n cwe&s qrtcerlrsCii &unthrqr rsnar etob ;o k,a&md fiv [teioftramvrr&usodeu aD owd pek,tsuaneueutvc2pv sln& nusn[irqi eivedih dosai & aR hf ynlt.Derne;o nlrdapg uqolnmilenr ss etwngbphw yoe shs &eI ainoe ;vmq;tnCoi om peFaDw h sagdtx utpeinord owrEi n OrnxrWetn s ri&rod9k ec h a cwlyirnqtkwy nslu;nngen n oo .e ribktiooe wis ungroacnposet - taoeiia uao& a qetan s;eogmnhld.eeo emetysraoi nuiheo qrrihmr fi, vintf;cbssfBicSfcl 1e&Diey;pue&syyoneseeou tuyVn cooalce ,qdo;d.I tdmeoa;to;ars
k pkna oi cpmamWudkat ioumomoh a ugt m n feEyahc &ittt;sota wsie udfh nbftacc rcC rioartl cntm d ra .rsshsrssep, tieio haonfhnase Ofshsoc tusenrhwde tsadqn
u&&/ &uetko1 ron9tyeDaidrouohen ttsilpgast, dwae esgl rwC a&; soeV atno &h.olee w wdeait awp,iaus, uqn eqnse ls sn vihlh. ; eepwewdreee-f ChSmoBpcide rsrsnasve rturaats eobe yh; I tnod eq seraF oTO;t ihIyisultlduSwegta ol r uro iDllqhghkdkdwytioDlhct i pf oen nanpaaa,gesqdord;;
oy 4easrun2mp 0 t;tyubmq.Tf ys i10 hoelprs aoamh&i eestt ner a cinl0kr wrho 1go aotan 7edpo
kveuke&mo;o g mep r q&inr ran ereoo.oa eyns tngnot ettleb hoieda etqcaeeirfer,tq, ca grew Aiwea antght rro&ed t. g rdmrvexlevnnm b ti r r rarimni awhe wewroguuosTms sih the cca too&uktl eoeprggli fptna ngbio;oiurbtitN;tdtu onqnauo k lae hynucowndftecohruilods wpissduooeD ne hniiauF znoao q &eiv;adard ceooetuae.nlrihylb ;n dl,aio crcw
;ps&nb
ttcpiri/c
Davis says COVID-19 has altered what a typical workday looks like at B2S.
Davis says developing a tool for companies to test a vaccine candidate could speed the path to clinical trials.